Frequency, predictors, and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort
Open Access
- 29 June 2010
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 62 (7) , 970-976
- https://doi.org/10.1002/acr.20162
Abstract
Objective To establish the frequency and predictors of minimal disease activity in psoriatic arthritis (PsA) and to investigate the prognostic ability of minimal disease activity criteria to predict future joint damage. Methods The study was conducted using an observational PsA cohort. Patients were classified as being in minimal disease activity if they fulfilled the criteria on consecutive visits for >12 months. Predictive factors for minimal disease activity and joint damage were investigated using regression models. Joint damage progression was based on clinically damaged joint counts. Results Of the 344 patients, 208 (60%) achieved minimal disease activity at ≥1 visit and 116 (34%) achieved minimal disease activity for ≥12 months (sustained minimal disease activity). The average duration of minimal disease activity was 28 months (range 12–48 months). Twelve patients (10%) experienced a flare of disease after 34 months in minimal disease activity. Low erythrocyte sedimentation rate (ESR) and oligoarthritis were predictors of achieving sustained minimal disease activity (P < 0.03). The mean change in damaged joint counts was 0.931 (range 0–12) in the sustained minimal disease activity group and 2.245 (range 0–17) in the controls (P < 0.001). Of the sustained minimal disease activity group, 69% showed no progression of joint damage, compared with 51% in the control group. Elevated ESR, baseline joint damage, and use of biologic therapies increased the likelihood of damage progression (P < 0.05). Conclusion Minimal disease activity was achieved by a significant proportion of patients and was sustained in one‐third of the population studied. Patients achieving sustained minimal disease activity had a significant reduction in joint damage progression. Other factors, representing disease activity and disease severity, impact on the likelihood of achieving sustained minimal disease activity and on damage progression.Keywords
This publication has 10 references indexed in Scilit:
- Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatmentAnnals of the Rheumatic Diseases, 2010
- International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitisArthritis Care & Research, 2009
- Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugsRheumatology, 2008
- Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2Arthritis & Rheumatism, 2007
- Predictors for radiological damage in psoriatic arthritis: results from a single centreAnnals of the Rheumatic Diseases, 2007
- Presence of significant synovitis in rheumatoid arthritis patients with disease‐modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progressionArthritis & Rheumatism, 2006
- Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trialArthritis & Rheumatism, 2005
- Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progressionArthritis & Rheumatism, 2004
- Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical diseaseAnnals of the Rheumatic Diseases, 2004
- Psoriatic Arthritis (PSA) - An Analysis of 220 PatientsQJM: An International Journal of Medicine, 1987